Beyond modest lipid improvements, GLP-1 receptor agonists have demonstrated substantial cardiovascular benefits in large-scale outcome trials, establishing them as important cardioprotective agents for appropriate patients
The balance of the carnitine pool is essential for maintaining organ function and is a promising target for the intervention and treatment of diseases
INCRETINS Release from the gut of incretin hormones (GIP and GLP-1) is responsible for amplification of insulin secretion, which occurs when nutrients are taken orally rather than being infused intravenously [1]
The peptide activates the PI3K/Akt signaling cascade, leading to translocation of GLUT4 glucose transporters to the cell membrane and increased cellular glucose uptake
Ghasemi, M., Phillips, C., Fahimi, A., McNerney, M